Aigen Investment Management, LP Catalyst Pharmaceuticals, Inc. Transaction History

Aigen Investment Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$11.78 - $17.29 $303,181 - $444,992	25,737 Added 144.75%	43,517 $731,000
Q3 2023 Nov 13, 2023	SELL	$11.69 - $15.02 $36,297 - $46,637	-3,105 Reduced 14.87%	17,780 $207,000
Q2 2023 Aug 14, 2023	BUY	$11.5 - $18.08 $240,177 - $377,600	20,885 New	20,885 $280,000
Q3 2022 Nov 09, 2022	BUY	$7.06 - $15.52 $409,381 - $899,942	57,986 New	57,986 $744,000
Q1 2020 May 08, 2020	SELL	$2.61 - $5.21 $39,862 - $79,572	-15,273 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$3.67 - $5.7 $56,051 - $87,056	15,273 New	15,273 $57,000

326

94.6M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.